Cel-Sci completes direct public offering

Cel-Sci Corp. (NYSE-A:CVM), Vienna, Va. Business: Cancer, Infectious Date completed: 6/19/12 Type: Direct public offering Raised: $5.6 million Shares: 16 million Price: $0.35 Shares after offering: 27...